Petros Pharmaceuticals (PTPI) Competitors $0.05 0.00 (-6.88%) As of 09:57 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock PTPI vs. TRAW, CSCI, CHRO, HCWB, KPRX, GELS, TLPH, IBIO, AIMD, and ACXPShould you be buying Petros Pharmaceuticals stock or one of its competitors? The main competitors of Petros Pharmaceuticals include Traws Pharma (TRAW), COSCIENS Biopharma (CSCI), Chromocell Therapeutics (CHRO), HCW Biologics (HCWB), Kiora Pharmaceuticals (KPRX), Gelteq (GELS), Talphera (TLPH), iBio (IBIO), Ainos (AIMD), and Acurx Pharmaceuticals (ACXP). These companies are all part of the "pharmaceutical products" industry. Petros Pharmaceuticals vs. Traws Pharma COSCIENS Biopharma Chromocell Therapeutics HCW Biologics Kiora Pharmaceuticals Gelteq Talphera iBio Ainos Acurx Pharmaceuticals Petros Pharmaceuticals (NASDAQ:PTPI) and Traws Pharma (NASDAQ:TRAW) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, community ranking, institutional ownership, profitability and media sentiment. Is PTPI or TRAW more profitable? Petros Pharmaceuticals has a net margin of 0.00% compared to Traws Pharma's net margin of -62,294.25%. Traws Pharma's return on equity of 0.00% beat Petros Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Petros PharmaceuticalsN/A -78.22% -23.50% Traws Pharma -62,294.25%N/A -822.38% Do institutionals and insiders hold more shares of PTPI or TRAW? 12.3% of Petros Pharmaceuticals shares are owned by institutional investors. Comparatively, 7.9% of Traws Pharma shares are owned by institutional investors. 12.3% of Petros Pharmaceuticals shares are owned by insiders. Comparatively, 13.6% of Traws Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer PTPI or TRAW? Petros Pharmaceuticals received 1 more outperform votes than Traws Pharma when rated by MarketBeat users. CompanyUnderperformOutperformPetros PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo VotesTraws PharmaN/AN/A Which has better valuation & earnings, PTPI or TRAW? Petros Pharmaceuticals has higher revenue and earnings than Traws Pharma. Traws Pharma is trading at a lower price-to-earnings ratio than Petros Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetros Pharmaceuticals$5.11M0.52-$8.16M-$4.76-0.01Traws Pharma$226K38.17-$18.95M-$40.90-0.04 Does the media refer more to PTPI or TRAW? In the previous week, Traws Pharma had 2 more articles in the media than Petros Pharmaceuticals. MarketBeat recorded 2 mentions for Traws Pharma and 0 mentions for Petros Pharmaceuticals. Petros Pharmaceuticals' average media sentiment score of 0.00 equaled Traws Pharma'saverage media sentiment score. Company Overall Sentiment Petros Pharmaceuticals Neutral Traws Pharma Neutral Which has more risk and volatility, PTPI or TRAW? Petros Pharmaceuticals has a beta of 2.17, indicating that its share price is 117% more volatile than the S&P 500. Comparatively, Traws Pharma has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. SummaryPetros Pharmaceuticals beats Traws Pharma on 9 of the 13 factors compared between the two stocks. Get Petros Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PTPI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTPI vs. The Competition Export to ExcelMetricPetros PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.68M$6.53B$5.39B$7.61BDividend YieldN/A3.21%5.44%4.33%P/E Ratio-0.017.1022.1918.24Price / Sales0.52255.77395.65104.08Price / CashN/A65.6738.2034.62Price / Book0.016.316.734.18Net Income-$8.16M$142.23M$3.20B$247.43M7 Day PerformanceN/A11.43%6.53%6.99%1 Month PerformanceN/A-6.40%-5.69%-2.60%1 Year PerformanceN/A-1.89%15.63%3.70% Petros Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTPIPetros Pharmaceuticals0.1919 of 5 stars$0.05-6.9%N/A-91.7%$2.68M$5.11M-0.0120Gap DownTRAWTraws Pharma0.3448 of 5 stars$1.76-11.1%N/AN/A$8.93M$226,000.00-0.0117CSCICOSCIENS BiopharmaN/A$3.05+7.8%N/AN/A$8.89M$9.59M-0.2620Gap UpCHROChromocell TherapeuticsN/A$1.43-22.3%N/A+10.7%$8.73MN/A-0.974Gap UpHCWBHCW BiologicsN/A$7.77+10.2%N/A-87.8%$8.73M$2.57M-7.7740Gap DownKPRXKiora Pharmaceuticals3.4124 of 5 stars$2.87+2.9%$10.00+248.4%-30.8%$8.61M$16M2.7610Positive NewsGELSGelteqN/A$0.90-2.8%N/AN/A$8.49MN/A0.00N/ALockup ExpirationNews CoverageGap UpHigh Trading VolumeTLPHTalphera2.2415 of 5 stars$0.49+3.2%$4.33+784.4%-46.5%$8.38M$281,000.00-0.7119Positive NewsIBIOiBio1.1661 of 5 stars$0.85-4.7%$4.30+407.2%-60.9%$8.37M$375,000.000.00100News CoverageAIMDAinos0.9146 of 5 stars$0.54-2.0%N/A-46.6%$8.32M$20,729.00-0.3340News CoverageACXPAcurx Pharmaceuticals2.1008 of 5 stars$0.37-1.0%$12.00+3,152.0%-81.0%$8.27MN/A-0.343Positive News Related Companies and Tools Related Companies Traws Pharma Competitors COSCIENS Biopharma Competitors Chromocell Therapeutics Competitors HCW Biologics Competitors Kiora Pharmaceuticals Competitors Gelteq Competitors Talphera Competitors iBio Competitors Ainos Competitors Acurx Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PTPI) was last updated on 4/23/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PTPI Stock Free PTPI Stock Alerts